A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs

Veterinary Microbiology

Volumn 53, Issue 1-2, 1996, Pages 181-189

  Strube, W ^a   Auer, S ^a   Block, W ^a   Heinen, E ^a   Kretzdorn, D ^a   Rodenbach, C ^a   Schmeer, N ^a  

^a BAYER AG   (Germany)

Author keywords

BHV1; BHV1 control programs; gE deletion; Marker vaccine

Indexed keywords

HERPES VACCINE; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BOVINE HERPES VIRUS; CONFERENCE PAPER; CONTROLLED STUDY; DELETION MUTANT; HERPES VIRUS INFECTION; INFECTION CONTROL; INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS; NONHUMAN; VACCINATION; VETERINARY MEDICINE; VIRUS MUTANT;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CATTLE; CATTLE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPEAN UNION; FEMALE; GENE DELETION; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; INFECTIOUS BOVINE RHINOTRACHEITIS; MALE; PREGNANCY; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

ANIMALIA; BOS TAURUS; BOVINAE; BOVINE HERPESVIRUS 1; BOVINE RHINOTRACHEITIS VIRUS; HERPES; HERPESVIRIDAE; HERPESVIRUS 1;

EID: 0030292542     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(96)01246-1     Document Type: Conference Paper

References (13)

1. Bosch, J.C., Frankena, K., Franken, P., Hage, J.J., De Jong, M.C.M., Kaashoek, M.J., Maris-Veldhuis, M.A., Noordhuizen, J.P.T.M., Vandehoek, J., Van der Poel, W.H.M., Verhoeff, J., Weerdmeester, K., Zimmer, G.M. and Van Oirschot, J.T., 1995a. Bovine herpesvirus 1 marker vaccines reduce the transmission of field virus in vaccinated populations. Vet. Microbiol., submitted.
2. Bosch, J.C., De Jong, M.C.M., Maissan, J. and Van Oirschot, J.T., 1995b. Quantification of experimental transmission of bovine herpesvirus 1 in cattle vaccinated with marker vaccines. Vet. Microbiol., submitted.
3. Commission of the European Communities, Directorate-General III/C-3, III/3181/91-EN: General Requirements for the Production and Control of Inactivated Mammalian Bacterial and Viral Vaccines for Veterinary Use, by the CVMP working party on immunological veterinary medicinal products.
4. Commission of the European Communities, Directorate-General III/C-3, III/3182/91-EN: General Requirements for the Production and Control of Live Mammalian Bacterial and Viral Vaccines for Veterinary Use, by the CVMP working party on immunological veterinary medicinal products.
5. Commission of the European Communities, Directorate-General III/C-3, III/3487/92-EN: Guidelines for Bovine Vaccines, by the CVMP working party on immunological veterinary medicinal products.
6. Flores, E.F., Osorio, F.A., Zanella, E.L., Kit, S. and Kit, M., 1993. Efficacy of a deletion mutant bovine herpesvirus-1 (BHV-1) vaccine that allows serological differentiation of vaccinated from naturally infected animals. J. Vet. Diagn. Invest., 5: 534-540.
7. Frerichs, G.N., Woods, S.B., Lucas, M.H. and Sands, J.J., 1982. Safety and efficacy of live and inactivated infectious bovine rhinotracheitis vaccines. Res. Vet. Sci., 111: 116-122.
8. Kaashoek, M.J., Moerman, A., Madic, J., Rijsewijk, F.A.M., Quak, J., Gielkens, A.L.J. and Van Oirschot, J.T., 1994. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine, 12: 439-444.
9. Kaashoek, M.J., Moerman, A., Madic, J., Weerdmeester, K., Maris-Veldhuis, M., Rijsewijk, F.A.M., and Van Oirschot, J.T., 1995. An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine, 13: 342-346.
10. Miller, J.M., Whetstone, C.A., Bello, L.J. and Lawrence, W.C., 1991. Determination of ability of a thymidine kinase-negative deletion mutant of bovine herpesvirus-1 to cause abortion in cattle. Am. J. Vet. Res., 52: 1038-1043.
11. Strube, W., Abar, B., Bergle, R.D., Block, W., Heinen E., Kretzdorn, D., Rodenbach, C. and Schmeer, N., 1995. Safety aspects in the development of an Infectious Bovine Rhinotracheitis marker vaccine. Dev. Biol. Stand., 84: 75-81.
12. Vaccinum rhinotracheitidis infectivae bovinae vivum cryodesiccatum, European Pharmacopeia (Infectious Bovine Rhinotracheitis Live Vaccine), Monogr. 696.
13. Zygraich, N., Lobmann, M., Vascoboinic, E., Berge, E. and Huygelen, C., 1974. In vivo and in vitro properties of a temperature sensitive mutant of infectious bovine rhinotracheitis virus. Res. Vet. Sci., 16: 328-335.